Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05294341 · ClinicalTrials.gov registry record · Phase 4
Metabolism of 0.35mg Norethindrone vs 5mg Norethindrone Acetate
A Phase 4 study, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 6
- Enrollment target
NCT05294341 is a Phase 4 study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 6 participants.
The verdict
NCT05294341, a Phase 4 study, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 6 participants
- Enrollment target
Study Summary
0.35mg norethindrone, also known as progesterone only pills, are routinely prescribed as immediate postpartum oral contraception. Norethindrone acetate is prescribed for gynecologic indications, but has never been studied as an efficacious form of contraception. This is a pilot crossover study examining the pharmacokinetics of norethindrone, the metabolically active component of both drugs, in participants taking 5mg norethindrone and 0.35mg norethindrone acetate.
Interventions
- DRUG Norethindrone Acetate 5 MG
- DRUG Norethindrone 0.35 MG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2022-07-22 |
| Est. Completion | 2023-05-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05294341
The ClinicalTrials.gov registry entry for NCT05294341 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Norethindrone Acetate 5 MG is the first listed.
NCT05294341 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05294341 about?
NCT05294341 is a clinical study titled "Metabolism of 0.35mg Norethindrone vs 5mg Norethindrone Acetate". 0.35mg norethindrone, also known as progesterone only pills, are routinely prescribed as immediate postpartum oral contraception. Norethindrone acetate is prescribed for gynecologic indications, but has never been studied as an efficacious form of contraception. This is a pilot crossover study exami...
What is the current status of trial NCT05294341?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 6 participants. The study started on 2022-07-22. Estimated completion is 2023-05-01.
What interventions are being tested in trial NCT05294341?
The interventions under investigation include: Norethindrone Acetate 5 MG (DRUG), Norethindrone 0.35 MG (DRUG).
Who is sponsoring clinical trial NCT05294341?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.